Substance Use & Addiction Journal (SAj)
@sajamersa.bsky.social
Substance Use & Addiction Journal (SAj) disseminates addiction-related original research, policy positions, & commentary. Peer reviewed. Dynamic. Owned by @AMERSA, Inc. https://amersa.org/about-the-journal/ Tweets&ReTweets are our own. EiC= @adamjgordon
"Among patients treated with buprenorphine or methadone, with each additional treatment month since baseline, those who continued with treatment appeared to be more likely to report 17% to 25% decreased odds of past 30-day nonprescribed opioid use."
October 22, 2025 at 11:52 AM
"Among patients treated with buprenorphine or methadone, with each additional treatment month since baseline, those who continued with treatment appeared to be more likely to report 17% to 25% decreased odds of past 30-day nonprescribed opioid use."